Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Biotechnol Bioeng. 2011 Aug 31;109(2):583–594. doi: 10.1002/bit.23302

Fig. 5.

Fig. 5

Immunofluorescence staining for CSPG in ESC-derived ECs before and after treatment with heparinase III. (Top panels) show that the surfaces of untreated ESC-derived ECs contain CSPG. Treatment with heparinase III did not change the intensity of CSPG fluorescence (Lower panels).